Shenzhen Neptunus Interlong Bio-Technique Co

Showing 1 posts of 1 posts found.

GSK takes control of China vaccines venture

June 15, 2011
Manufacturing and Production, Research and Development, Sales and Marketing China, GSK, Shenzhen Neptunus Interlong Bio-Technique Co, vaccines

GlaxoSmithKline is increasing its footprint in China, shelling out £24 million ($39 million) to buy the remaining stake in a …

The Gateway to Local Adoption Series

Latest content